Volume 42, Issue 7 | Neurochemical Research

Search all Neurochemical Research articles

Volume 42, Issue 7

July 2017

Special Issue in Honor of Steve White

Issue Editor:

Henrik Klitgaard

27 articles in this issue

Preface for the Steve White Honorary Issue of Neurochemical Research
Henrik Klitgaard
Preface 29 June 2017 Pages: 1865 - 1866
A Tribute to Steve White
Emilio Perucca
Commentary 01 October 2016 Pages: 1867 - 1868
H. Steve White: A Champion for Contemporary Epilepsy Research
Harold Kohn
Commentary 25 January 2017 Pages: 1869 - 1870
Steve White: A Hero for Patients with Epilepsy
Susan Axelrod
Commentary 14 February 2017 Pages: 1871 - 1872
Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs
Wolfgang Löscher
Original Paper 13 March 2017 Pages: 1873 - 1888
The Anticonvulsant Screening Program of the National Institute of Neurological Disorders and Stroke, NIH: History and Contributions to Clinical Care in the Twentieth Century and Beyond
Roger J. Porter
Harvey J. Kupferberg
Original Paper 09 March 2017 Pages: 1889 - 1893
The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP)
John H. Kehne
Brian D. Klein
Shalini Sharma
Original Paper Open access 02 May 2017 Pages: 1894 - 1903
Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy
Melissa L. Barker-Haliski
Kristina Johnson
Karen S. Wilcox
Original Paper 16 March 2017 Pages: 1904 - 1918
A Mesiotemporal Lobe Epilepsy Mouse Model
Duveau Venceslas
Roucard Corinne
Original Paper 23 March 2017 Pages: 1919 - 1925
The Search for New Screening Models of Pharmacoresistant Epilepsy: Is Induction of Acute Seizures in Epileptic Rodents a Suitable Approach?
Wolfgang Löscher
Original Paper 08 August 2016 Pages: 1926 - 1938
Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)
Brian D. Klein
Catherine A. Jacobson
John H. Kehne
Original Paper 06 May 2017 Pages: 1939 - 1948
Preclinical Screening for Treatments for Infantile Spasms in the Multiple Hit Rat Model of Infantile Spasms: An Update
Aristea S. Galanopoulou
Wenzhu B. Mowrey
Solomon L. Moshé
Original Paper 02 May 2017 Pages: 1949 - 1961
Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques
Lindsey R. Hamilton
Steven C. Schachter
Todd M. Myers
Original Paper 30 November 2016 Pages: 1962 - 1971
Design and Comparative Evaluation of the Anticonvulsant Profile, Carbonic-Anhydrate Inhibition and Teratogenicity of Novel Carbamate Derivatives of Branched Aliphatic Carboxylic Acids with 4-Aminobenzensulfonamide
David Bibi
Hafiz Mawasi
Meir Bialer
Original Paper 09 March 2017 Pages: 1972 - 1982
Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2
Cameron S. Metcalf
Misty D. Smith
Grzegorz Bulaj
Original Paper 06 April 2017 Pages: 1983 - 1994
Preclinical Comparison of Mechanistically Different Antiseizure, Antinociceptive, and/or Antidepressant Drugs in a Battery of Rodent Models of Nociceptive and Neuropathic Pain
Misty D. Smith
Jose H. Woodhead
Karen S. Wilcox
Original Paper 15 May 2017 Pages: 1995 - 2010
Ketone Bodies as Anti-Seizure Agents
Timothy A. Simeone
Kristina A. Simeone
Jong M. Rho
Original Paper 10 April 2017 Pages: 2011 - 2018
Delineation of the Role of Astroglial GABA Transporters in Seizure Control
Arne Schousboe
Karsten K. Madsen
Original Paper 11 February 2017 Pages: 2019 - 2023
Oxidative Stress Contributes to Status Epilepticus Associated Mortality
Jennifer N. Pearson-Smith
Li-Ping Liang
Manisha Patel
Original Paper 02 May 2017 Pages: 2024 - 2032
Proteomic Analysis After Status Epilepticus Identifies UCHL1 as Protective Against Hippocampal Injury
James P. Reynolds
Eva M. Jimenez-Mateos
David C. Henshall
Original Paper 10 April 2017 Pages: 2033 - 2054
Disease-Modifying Effects of Neural Regeneration Peptide 2945 in the GAERS Model of Absence Epilepsy
Gabi Dezsi
Frank Sieg
Nigel C. Jones
Original Paper 16 May 2017 Pages: 2055 - 2064
Neurodevelopmental Effects of Antiepileptic Drugs
Marissa Kellogg
Kimford J. Meador
Original Paper 19 April 2017 Pages: 2065 - 2070
Can Neurochemical Changes of Mood Disorders Explain the Increase Risk of Epilepsy or its Worse Seizure Control?
Andres M. Kanner
Original Paper 01 July 2017 Pages: 2071 - 2076
Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability
Torleiv Svendsen
Eylert Brodtkorb
Cecilie Johannessen Landmark
Original Paper 27 March 2017 Pages: 2077 - 2083
Genomics-Guided Precise Anti-Epileptic Drug Development
Norman Delanty
Gianpiero Cavallleri
Original Paper 12 June 2017 Pages: 2084 - 2088
Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions
Annamaria Vezzani
Rosaria Pascente
Teresa Ravizza
Original Paper 22 April 2017 Pages: 2089 - 2098
Strengthening the Case for Epilepsy Drug Development: Bridging Experiences from the Alzheimer’s Disease Field—An Opinion
Roy E. Twyman
Original Paper 07 June 2017 Pages: 2099 - 2115